Monitor this situation.

Unsubscribe anytime.

[SITUATION] · [QUIET] · [HEALTH]

29 clusters · 146 sources · 155 days · First seen 6 months ago · Last updated 22 days ago

PMOS: Cancer Risks, Symptoms, and Cognitive Health

Overview

Following the May 2026 international consensus renaming polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome (PMOS), new research and clinical developments have emerged regarding its management and risks.

In Australia, the renaming has been officially adopted to better reflect the disorder’s endocrine and metabolic features and to reduce misdiagnosis associated with ovarian cysts. Clinicians, including Dr. Rashmi Talwar of Agilus Diagnostics, emphasize recognizing early symptomatic indicators. Simultaneous shifts in skin, hair, weight, and menstruation—such as sudden acne, unexpected hair growth, and irregular menstrual cycles—may indicate underlying hormonal imbalances. Specifically, cycles that continuously lengthen or occur fewer than eight times a year warrant medical evaluation.

Recent large-scale research in the US has expanded the known risk profile of PMOS. An analysis of over 400,000 women linked the condition to significantly higher hazards for several reproductive cancers, with the strongest association being uterine cancer, where the hazard was ‘nearly six times higher’. This study also suggested increased risks for ovarian, fallopian tube, breast, and cervical cancers.

Further research published in the Journal of the Endocrine Society has identified a potential link between PMOS and an increased risk of dementia and cognitive impairment. Researchers from the US and Iran suggest this connection may be driven by metabolic factors, such as chronic insulin resistance and obesity, rather than the hormonal disorder itself. While measurable changes in brain structure and neurocognitive functions like working memory have been noted, clinical evidence specifically linking PMOS to Alzheimer's disease remains inconsistent. Experts suggest that optimizing metabolic health should remain a primary focus for affected women.

Entities

Polyendocrine Metabolic Ovarian Syndrome · Aeroflow Urology · Charlotte Touzalin · Melanie Cree · World Health Organization

Claims

What the coverage asserts, and how many sources carry each claim.

[● 3 SOURCES] The previous name, Polycystic Ovary Syndrome (PCOS), was considered misleading.
[● 3 SOURCES] As of May 2026, the condition formerly known as PCOS is officially renamed PMOS (Polyendocrine Metabolic Ovarian Syndrome).
[● 3 SOURCES] Most affected individuals do not have actual cysts, but rather many small, normal follicles.
[● 3 SOURCES] The condition involves multiple hormone systems and metabolic disorders, such as insulin resistance.
[● 3 SOURCES] Polyendocrine metabolic ovarian syndrome (PMOS) is associated with an increased risk of dementia and cognitive impairment.
[● 2 SOURCES] Clinical evidence specifically linking PMOS to Alzheimer's disease remains inconsistent.
[● 2 SOURCES] The review article was published online on October 13.
[○ 1 SOURCE] PMOS affects approximately 10% to 15% of women worldwide.

Timeline

22 days ago

[HEALTH] 6 sources
PMOS linked to increased dementia and Alzheimer's risk
A systematic review links PMOS (formerly PCOS) to increased dementia risk, suggesting metabolic issues like insulin resistance may be the primary driver rather than hormonal changes alone.
about 1 month ago

[HEALTH] 4 sources
PMOS symptoms include acne and irregular menstruation
Medical experts discuss the signs of Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly PCOS, including irregular menstruation, acne, and hair growth.
about 2 months ago

[HEALTH] 4 sources
PMOS linked to increased risk of reproductive cancers
A major US study links PMOS (formerly PCOS) to significantly higher risks of uterine, ovarian, breast, and cervical cancers, while advocates call for improved global women's health education.
about 2 months ago

[HEALTH] 3 sources
PMOS: Medical name change for PCOS officially implemented
Effective May 2026, Polycystic Ovary Syndrome (PCOS) is officially renamed PMOS (Polyendocrine Metabolic Ovarian Syndrome) to better reflect its complex hormonal and metabolic impacts.
2 months ago

[HEALTH] 7 sources
Medical experts rename PCOS to Polyendocrine Metabolic Ovarian Syndrome
Polycystic Ovary Syndrome (PCOS) has been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) to better reflect its nature as a multisystem metabolic and endocrine disorder.
2 months ago

[HEALTH] 4 sources
Medical experts rename PCOS to PMOS to reflect metabolic impact
Polycystic ovarian syndrome is being renamed polyendocrine metabolic ovarian syndrome (PMOS) to reflect its status as a multisystem metabolic and endocrine disorder driven by insulin resistance.
2 months ago

[HEALTH] 2 sources
Polycystic ovary syndrome renamed to reflect metabolic complexity
Polycystic ovary syndrome is being renamed polyendocrine metabolic ovarian syndrome (PMOS) to reflect its complex metabolic nature, while researchers use data mining to improve diagnostic accuracy.
3 months ago

[HEALTH] 4 sources
GLP-1 drugs show promise in treating PMOS hormonal disorder
GLP-1 obesity medications are showing promise in treating polyendocrine metabolic ovarian syndrome (PMOS) by improving insulin resistance and hormone balance in affected women.
3 months ago

[HEALTH] 7 sources
GLP-1 drugs show promise in treating PMOS hormonal disorder
GLP-1 obesity drugs show potential in treating Polyendocrine Metabolic Ovarian Syndrome (PMOS), while a new specialized screening service is set to launch in Jersey to improve diagnosis.
3 months ago

[HEALTH] 3 sources
PCOS renamed PMOS to highlight hormonal and metabolic nature
PCOS, affecting up to 15% of women, is often linked to insulin resistance. Australian experts have renamed it PMOS to better describe its hormonal and metabolic nature and improve diagnosis.
3 months ago

[HEALTH] 3 sources
Polyendocrine Metabolic Ovarian Syndrome Linked to Cardiovascular Risk in Women with Type 1 Diabetes
Research shows PMOS does not worsen lipid profiles in women with Type 1 diabetes but is linked to higher cardiovascular risk, underscoring the need for targeted studies.
3 months ago

[HEALTH] 2 sources
PMOS Tied to Quadruple Heart Disease Risk and Fertility Challenges
U.S. research links PMOS to a fourfold rise in heart disease risk and highlights fertility issues, urging early diagnosis, cardiovascular monitoring, and lifestyle‑based treatments.
3 months ago

[HEALTH] 2 sources
Women with PMOS face fourfold higher risk of heart disease, study shows
Research links PMOS to higher anxiety, depression and a fourfold increase in heart disease risk, urging comprehensive treatment and lifestyle changes.
4 months ago

[HEALTH] 2 sources
Polycystic Ovary Syndrome Linked to Higher Heart Disease Risk
A Lancet study of 400,000 U.S. women with polycystic ovary syndrome (now called SOMP) shows a higher risk of cardiovascular disease, even absent traditional risk factors.
4 months ago

[HEALTH] 7 sources
PMOS (formerly PCOS) linked to fourfold rise in women's heart disease risk
Research shows women with PMOS face a four‑fold higher heart disease risk, spurring calls for routine screening and a name change from PCOS to reflect its systemic impact.
4 months ago

[HEALTH] 2 sources
PMOS (Former PCOS) Causes and Treatment Options Detailed
PMOS (formerly PCOS) affects up to 13% of women; causes include genetics, hormones, insulin resistance, inflammation, and obesity. Treatments range from weight loss and letrozole to metformin and IVF/IVM.
4 months ago

[HEALTH] 10 sources
NICE urges annual NHS checks for 4 million women with PMOS
NICE draft guidance urges NHS to screen up to 4 million UK women for PMOS and provide annual health checks, while rejecting NHS‑funded laser hair removal.
5 months ago

[HEALTH] 2 sources
WHO and IES rename PCOS to polycystic ovary and adrenal syndrome
WHO and the International Endocrine Society have renamed PCOS to polycystic ovary and adrenal syndrome, emphasizing its metabolic and adrenal aspects and prompting broader screening and research.
5 months ago

[HEALTH] 3 sources
Polycystic ovary syndrome reclassified as metabolic syndrome (PMOS)
The Lancet‑backed consensus renames PCOS as PMOS, adding metabolic criteria and prompting a broader, lifestyle‑focused treatment approach.
5 months ago

[HEALTH] 2 sources
Polycystic ovary syndrome renamed polyendocrine metabolic ovarian syndrome (PMOS)
PCOS has been renamed polyendocrine metabolic ovarian syndrome (PMOS) to emphasize its hormonal and metabolic nature, aiming to improve diagnosis and comprehensive care.
5 months ago

[HEALTH] 2 sources
Syndrome métabolique ovarien polyendocrinien renamed to highlight metabolic and cardiovascular risks
European endocrinology congress renamed PCOS to SMOP, highlighting its metabolic and cardiovascular risks; the condition affects about 1 in 10 women in France and 170 million worldwide.
5 months ago

[HEALTH] 2 sources
International medical community renames PCOS to PMOS
The PCOS condition is officially renamed PMOS to highlight its endocrine and metabolic aspects, aiming to improve diagnosis, treatment and research funding.
5 months ago

[HEALTH] 3 sources
Polycystic Ovary Syndrome Recognized as Whole‑Body Metabolic Disorder
PCOS is a whole‑body disorder with hormonal, metabolic and cardiovascular risks, while endometriosis shares some symptoms but stems from ectopic tissue and inflammation.
6 months ago

[HEALTH] 2 sources
PCOS renamed PMOS in global consensus, sparking Indian criticism
Global experts rename PCOS to PMOS to stress metabolic aspects, but Indian scientists protest the change as Western‑centric and potentially confusing.
6 months ago

[HEALTH] 3 sources
PCOS (PMOS) Spotlight: Dietary Tips and Keke Palmer’s Diagnosis Journey
New PMOS name and diet tips highlight PCOS impact, with Keke Palmer sharing her diagnosis struggle.
6 months ago

[HEALTH] 9 sources
PMOS replaces PCOS as new name for common women's endocrine disorder
PCOS renamed PMOS to highlight endocrine and metabolic features, improving diagnosis and research for the condition affecting ~170 million women.
6 months ago

[HEALTH] 7 sources
International Consensus Renames PCOS to Polyendocrine Metabolic Ovarian Syndrome
Global experts rename PCOS to Polyendocrine Metabolic Ovarian Syndrome, reflecting broader hormonal and metabolic effects.
6 months ago

[HEALTH] 9 sources
PCOS Renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) Worldwide
PCOS is renamed PMOS to highlight its endocrine and metabolic nature, improving diagnosis for 170 million women worldwide.
6 months ago

[HEALTH] 43 sources
Global Consensus Renames PCOS to PMOS, Aiming for Better Diagnosis
PCOS has been renamed polyendocrine metabolic ovarian syndrome (PMOS) after a global consensus, to better reflect its multisystem nature and improve care for ~

Sources

abc17news.com · archyde.com · archynewsy.com · austinchronicle.com · auto.com.tr · bailiwickexpress.com · bikeregister.com · birminghammail.co.uk · bizzmarkblog.com · blackdoctor.org · blogdovaldemir.com.br · brignews.com · businessnewsthisweek.com · bwhi.org · ca.sports.yahoo.com · cantika.com · capitalnews.com.br · cinenews.be · clovermedia.jp · contramuro.com · ctinc.com · deutschesgesundheitsportal.de · diariodeleon.es · dnoticias.pt · e-sante.fr · ebc.com.au · ekbis.harianjogja.com · el-nacional · elimparcial · elle.de · elorientaldemonagas.com · emjreviews.com · enavabharat.com · english.madhyamam.com · epochtimes.com · exerciseright.com.au · expressindia.com · factsaboutfertility.org · fehmarn24.de · fertilityauthority.com · filmow.com · forchecaudine.it · Fortune.com · freerepublic.com · G1 - G1 - Todas as notícias · Google News Health CA (FR) · Google News Health GB · gravidanzaonline.it

This summary has been updated 9 times: see revision history